Allison Cushman-Vokoun MD, PhD

Department Affiliations

Medical Director, Molecular Diagnostics Laboratory
Medical Director, Warren G. Sanger Human Genetics Laboratory

Molecular Genetics of Solid Tumors, Inherited Diseases, Hereditary Cancer Syndromes, Pharmacogenomics, Molecular Pathology Education

Education and Training
Washington University in St. Louis, Bachelor of Arts and Sciences, Biology and Ancient Studies - 1996
University of Nebraska Medical Center Doctor of Philosophy, Pharmacology - 2002
University of Nebraska Medical Center Doctor of Medicine - 2004
AP/CP Residency Training Program Department of Pathology, Microbiology and Immunology University of Nebraska Medical Center - 2008
Molecular Genetic Pathology Fellowship Department of Pathology Vanderbilt University Medical Center - 2009

Teaching Activities
Organizer and Lecturer for the Molecular Didactic Course for the Pathology Residents and Cytotechnology Trainees
Faculty teaching/signout during Molecular and Chemistry Resident Rotations
Involved with mentoring and clinical rotations in the UNMC MD/PhD program
PBL Facilitator for M1 and M2 students

National Activities
Member, Nebraska Association of Pathologists
Member, United States and Canadian Academy of Pathology
Member, Association for Molecular Pathology
Fellow, College of American Pathologists
Member, American Society for Clinical Pathology

Notable Publications

Two cases of Mazabraud syndrome and identification of a GNAS R201H mutation by next-generation sequencing.  Cox JL, Cushman-Vokoun AM, McGarry SV, Kozel JA.  Virchows Arch. 2017 Mar 3. doi: 10.1007/s00428-017-2100-8. [Epub ahead of print] No abstract available.

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology.  Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA.  J Clin Oncol. 2017 Feb 6:JCO2016719807. doi: 10.1200/JCO.2016.71.9807. [Epub ahead of print]

Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non–Small-Cell Lung Cancer.  Vijaya Raj Bhatt, Sanyo P. D’Souza, Lynette M. Smith, Cushman-Vokoun AM, Vanita Noronha, Vivek Verma, Amit Joshi, Anuradha Chougule, Nirmala Jambhekar, Anne Kessinger, Alissa Marr, Vijay Patil, Sripad D. Banavali, Apar Kishor Ganti, Kumar Prabhash.   Journal of Global Oncology, DOI: 10.1200/JGO.2016.003392 Journal of Global Oncology - published online before print October 28, 2016

QIAGEN Therascreen KRAS RGQ Assay, QIAGEN KRAS Pyro Assay, and Dideoxy Sequencing for Clinical Laboratory Analysis of KRAS Mutations in Tumor Specimens.  Alqahtani QM, Crowley A, Rapp S, Cushman-Vokoun AM.  Lab Med. 2016 Feb;47(1):30-8. doi: 10.1093/labmed/lmv009.

Standards for Clinical Grade Genomic Databases.  Yohe SL, Carter AB, Pfeifer JD, Crawford JM, Cushman-Vokoun A, Caughron S, Leonard DG.  Arch Pathol Lab Med. 2015 Nov;139(11):1400-12. doi: 10.5858/arpa.2014-0568-CP.

Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.  Cushman-Vokoun AM, Stover DG, Zhao Z, Koehler EA, Berlin JD, Vnencak-Jones CL.  Clin Colorectal Cancer. 2013 Sep;12(3):168-78. doi: 10.1016/j.clcc.2013.04.005.

Comparison study of the performance of the QIAGEN EGFR RGQ and EGFR pyro assays for mutation analysis in non-small cell lung cancer.  Cushman-Vokoun AM, Crowley AM, Rapp SA, Greiner TC.  Am J Clin Pathol. 2013 Jul;140(1):7-19. doi: 10.1309/AJCPMF26ABEOYCHZ.

Molecular diagnostics of soft tissue tumors.  Bridge JA, Cushman-Vokoun AM.  Arch Pathol Lab Med. 2011 May;135(5):588-601. doi: 10.1043/2010-0594-RAIR.1. Review.

Assay design affects the interpretation of T-cell receptor gamma gene rearrangements: comparison of the performance of a one-tube assay with the BIOMED-2-based TCRG gene clonality assay.  Cushman-Vokoun AM, Connealy S, Greiner TC.  J Mol Diagn. 2010 Nov;12(6):787-96. doi:10.2353/jmoldx.2010.090183. 

For a detailed list of publications, click here.